2006
DOI: 10.1093/jac/dkl190
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial function in HIV-infected patients with low or mild cardiovascular risk

Abstract: HIV-infected patients receiving antiretroviral therapy who have low or mild cardiovascular risk and lipid levels within the normal range have endothelial dysfunction compared with healthy controls.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
29
2
1

Year Published

2008
2008
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(36 citation statements)
references
References 41 publications
4
29
2
1
Order By: Relevance
“…Most were intended to determine whether HIV infection, HAART and/or protease inhibitors induce endothelial dysfunction and to test whether this effect is dependent upon antiretroviral therapy mediated lipid disturbances. Accordingly, several studies investigated brachial artery flow mediated vasodilation (FMD) measured by high-resolution ultrasound during reactive hyperemia following transient forearm ischemia in HIV treated and naïve, untreated, patients and controls seronegative for HIV (100)(101)(102)(103)(104)(105). These early studies reached quite similar results: 1 -HIV-infected patients have significant impairment of endothelial function when compared with controls seronegative for HIV; 2 -patients treated with HAART/protease inhibitors had significantly lower FMD than untreated HIV patients (Table 5).…”
Section: Endothelial Dysfunctionmentioning
confidence: 99%
“…Most were intended to determine whether HIV infection, HAART and/or protease inhibitors induce endothelial dysfunction and to test whether this effect is dependent upon antiretroviral therapy mediated lipid disturbances. Accordingly, several studies investigated brachial artery flow mediated vasodilation (FMD) measured by high-resolution ultrasound during reactive hyperemia following transient forearm ischemia in HIV treated and naïve, untreated, patients and controls seronegative for HIV (100)(101)(102)(103)(104)(105). These early studies reached quite similar results: 1 -HIV-infected patients have significant impairment of endothelial function when compared with controls seronegative for HIV; 2 -patients treated with HAART/protease inhibitors had significantly lower FMD than untreated HIV patients (Table 5).…”
Section: Endothelial Dysfunctionmentioning
confidence: 99%
“…In contrast to several previous trials, 11,13 HIV-infected and HIV-uninfected participants in this study were homogeneous with respect to gender, race, and diagnosis of/treatment for hyperlipidemia. Despite differences between HIV treatment groups, age and lipid values were similar between the HIV-infected and HIV-uninfected groups.…”
Section: Discussionmentioning
confidence: 60%
“…[1][2][3][4][5][6] Highly unsaturated omega-3 fatty acids and dietary antioxidants may reverse this effect. [6][7][8][9] HIV has also been associated with impaired FMD in several studies, [10][11][12][13] though this is not a universal finding. 14,15 Impaired endothelial function precedes atherosclerosis and is independent of other cardiovascular (CV) risk factors.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hypoadiponectinemia is one of the factors responsible for lipodystrophy and metabolic disorder in HIV patients receiving PI 9,10 . Endothelial dysfunction is a premature event in the development of atherosclerotic lesions and may be easily measured using non-invasive ultrasound study of the brachial artery flow 11 . The mechanisms that lead to endothelial dysfunction in HIV-positive patients receiving PI remain not fully understood.…”
Section: Introductionmentioning
confidence: 99%